The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The fiscal year 2025 closed with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
Covalent drugs, a class of therapeutics that form irreversible or quasi-irreversible bonds with their biological targets, have undergone a remarkable…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The fiscal year 2025 concluded with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern therapeutics has been significantly shaped by covalent drugs, a class of pharmaceuticals distinguished by their ability…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The pharmaceutical landscape of Fiscal Year 2025 witnessed a dynamic reshuffling at its apex, with Merck’s Keytruda steadfastly holding its…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The fiscal year 2025 witnessed a dramatic recalibration at the apex of the pharmaceutical industry’s sales leaderboard, characterized by a…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern medicine has been profoundly shaped by therapeutic agents that form stable, enduring bonds with their biological…
Read More
Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers
In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…
Read MoreYOU MAY HAVE MISSED
